Skip to main content
. 2020 Feb 11;12(2):199. doi: 10.3390/v12020199

Table 1.

Overview of antiviral activity of LUMS1 and compounds used as positive control.

Assay System Inhibitor EC50 (nM)
HCVcc LUMS1 45.3 ± 18.6
MVN # 35.6 ± 3.98
HCV replicon LUMS1 n.d.
Sofosbuvir 54.0 ± 32.8
HCVpp LUMS1 142.1 ± 23.0
HIV-1 single
round infectivity
LUMS1 37.2 ± 4.4
MVN 8.0 ± 1.4

# Dose response curve is given in Figure S3, Supplementary Material.